These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4042527)

  • 41. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.
    McLenachan JM; Grant S; Ford I; Henderson E; Dargie HJ
    Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma.
    Carlson C; Järvinen KA
    Allergy; 1978 Jun; 33(3):147-51. PubMed ID: 707790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
    Mucklow JC; Kuhn S
    Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.
    Boulet LP; Lacourcière Y; Milot J; Lampron N
    Br J Clin Pharmacol; 1990 Jun; 29(6):725-31. PubMed ID: 2198911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
    Ellis ME; Hussain M; Webb AK; Barker NP; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):59S-64S. PubMed ID: 6743475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of pafenolol and metoprolol on ventilatory function and haemodynamics during exercise by asthmatic patients.
    Löfdahl CG; Marlin GE; Svedmyr N
    Eur J Clin Pharmacol; 1983; 24(3):289-95. PubMed ID: 6134621
    [No Abstract]   [Full Text] [Related]  

  • 50. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH; McNeill AJ; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
    Kaiser P; Hylander B; Eliasson K; Kaijser L
    Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
    Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
    Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate.
    Appel D; Karpel JP; Sherman M
    J Allergy Clin Immunol; 1989 Jul; 84(1):90-8. PubMed ID: 2754149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Atenolol in the treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1998 Feb; 4(20):89-91. PubMed ID: 9591440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Verofylline, a methylxanthine bronchodilator, in asthma.
    Young RC; Lucas SG; Morris EA; Pittman J; Rachal RE; Malveaux FJ; Booker WM
    Clin Pharmacol Ther; 1984 Dec; 36(6):811-6. PubMed ID: 6388955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
    Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
    Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoceptor antagonists in man.
    Taylor EA; Trembath PW; Warrington SJ
    Br J Clin Pharmacol; 1981 Aug; 12(2):201-9. PubMed ID: 6118171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.